Navigation Links
GM canola ban "disappointing"
Date:2/8/2008

The South Australian Governments decision to extend a moratorium on genetically modified canola is not supported by scientific evidence and may send the wrong message about the role of science in agriculture, experts in plant science and technology say.

The experts based at the Australian Centre for Plant Functional Genomics (ACPFG) at the University of Adelaides Waite Campus say Australian farmers should be provided with every technology, whether GM or not, to help overcome the ravaging effects of national problems such as drought and salinity.

The State Governments decision is disappointing says University of Adelaide Federation Fellow Professor Mark Tester, and the Director of the Universitys Waite Campus, Professor Geoff Fincher, both based at the ACPFG.

This decision is not supported by the extensive scientific evidence that has been accumulated over 10 years in many countries around the world and could send negative signals to the community about the potential benefits of science and the application of new technologies, Professor Tester says.

Currently the Australian Federal Government, through the Office of the Gene Technology Regulator, monitors all genetic modification research on a case-by-case basis, under stringent control guidelines.

Most cases show that in recent years, countries with access to genetically modified crops have reaped environmental benefits, particularly in the developing world. There is little doubt in the scientific community that genetic modification is part of a sustainable farming future, says the Director of the University of Adelaides Waite Campus and Deputy CEO of the ACPFG, Professor Geoff Fincher.

We need to ensure that the community is properly informed of the issues related to the application of this technology. We hope that South Australian farmers will be given the opportunity to use this technology in the future for the benefit of farmers, consumers and the environment, Professor Tester says.


'/>"/>

Contact: Mark Tester
mark.tester@acpfg.com.au
61-883-037-159
University of Adelaide
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: